| Product Code: ETC13359864 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Africa Human Microbiome-Based Drugs and Diagnostics Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Africa Human Microbiome-Based Drugs and Diagnostics Market Overview |
3.1 Africa Regional Macro Economic Indicators |
3.2 Africa Human Microbiome-Based Drugs and Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 Africa Human Microbiome-Based Drugs and Diagnostics Market - Industry Life Cycle |
3.4 Africa Human Microbiome-Based Drugs and Diagnostics Market - Porter's Five Forces |
3.5 Africa Human Microbiome-Based Drugs and Diagnostics Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Africa Human Microbiome-Based Drugs and Diagnostics Market Revenues & Volume Share, By Drug Category, 2021 & 2031F |
3.7 Africa Human Microbiome-Based Drugs and Diagnostics Market Revenues & Volume Share, By Diagnostic Category, 2021 & 2031F |
3.8 Africa Human Microbiome-Based Drugs and Diagnostics Market Revenues & Volume Share, By Target Organism, 2021 & 2031F |
3.9 Africa Human Microbiome-Based Drugs and Diagnostics Market Revenues & Volume Share, By Application Area, 2021 & 2031F |
3.10 Africa Human Microbiome-Based Drugs and Diagnostics Market Revenues & Volume Share, By End Use, 2021 & 2031F |
4 Africa Human Microbiome-Based Drugs and Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Africa Human Microbiome-Based Drugs and Diagnostics Market Trends |
6 Africa Human Microbiome-Based Drugs and Diagnostics Market, 2021 - 2031 |
6.1 Africa Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Drug Category, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Africa Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Probiotics, 2021 - 2031 |
6.1.3 Africa Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Prebiotics, 2021 - 2031 |
6.1.4 Africa Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Symbiotics, 2021 - 2031 |
6.1.5 Africa Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Fecal Transplant, 2020 - 2028 |
6.2 Africa Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Diagnostic Category, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Africa Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Microbial Profiling, 2021 - 2031 |
6.2.3 Africa Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Microbial DNA Testing, 2021 - 2031 |
6.2.4 Africa Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Polymerase Chain Reaction (PCR), 2021 - 2031 |
6.2.5 Africa Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Genomic Profiling, 2021 - 2031 |
6.3 Africa Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Target Organism, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Africa Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Gut Microbiome, 2021 - 2031 |
6.3.3 Africa Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Oral Microbiome, 2021 - 2031 |
6.3.4 Africa Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Skin Microbiome, 2021 - 2031 |
6.3.5 Africa Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Vaginal Microbiome, 2021 - 2031 |
6.4 Africa Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Application Area, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Africa Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Gastrointestinal Health, 2021 - 2031 |
6.4.3 Africa Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Oral Health, 2021 - 2031 |
6.4.4 Africa Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Dermatological Disorders, 2020 - 2028 |
6.4.5 Africa Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Immune Modulation, 2020 - 2028 |
6.5 Africa Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By End Use, 2020 - 2028 |
6.5.1 Overview & Analysis |
6.5.2 Africa Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Digestive Disorders, 2020 - 2028 |
6.5.3 Africa Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Periodontal Disease, 2020 - 2028 |
6.5.4 Africa Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Skin Health, 2020 - 2028 |
6.5.5 Africa Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Vaginal Health, 2020 - 2028 |
7 Africa Human Microbiome-Based Drugs and Diagnostics Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Africa Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Drug Category, 2021 - 2031 |
7.2.1 South Africa Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Drug Category, 2021 - 2031 |
7.2.2 Egypt Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Drug Category, 2021 - 2031 |
7.2.3 Nigeria Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Drug Category, 2021 - 2031 |
7.2.4 Rest of Africa Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Drug Category, 2021 - 2031 |
7.3 Africa Human Microbiome-Based Drugs and Diagnostics Market Revenues & Volume Share, By Diagnostic Category, 2021 & 2031F |
7.3.1 South Africa Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Diagnostic Category, 2021 - 2031 |
7.3.2 Egypt Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Diagnostic Category, 2021 - 2031 |
7.3.3 Nigeria Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Diagnostic Category, 2021 - 2031 |
7.3.4 Rest of Africa Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Diagnostic Category, 2021 - 2031 |
7.4 Africa Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Target Organism, 2021 - 2031 |
7.4.1 South Africa Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Target Organism, 2021 - 2031 |
7.4.2 Egypt Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Target Organism, 2021 - 2031 |
7.4.3 Nigeria Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Target Organism, 2021 - 2031 |
7.4.4 Rest of Africa Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Target Organism, 2021 - 2031 |
7.5 Africa Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Application Area, 2021 - 2031 |
7.5.1 South Africa Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Application Area, 2021 - 2031 |
7.5.2 Egypt Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Application Area, 2021 - 2031 |
7.5.3 Nigeria Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Application Area, 2021 - 2031 |
7.5.4 Rest of Africa Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Application Area, 2021 - 2031 |
7.6 Africa Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By End Use, 2021 - 2031 |
7.6.1 South Africa Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By End Use, 2021 - 2031 |
7.6.2 Egypt Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By End Use, 2021 - 2031 |
7.6.3 Nigeria Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By End Use, 2021 - 2031 |
7.6.4 Rest of Africa Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By End Use, 2021 - 2031 |
8 Africa Human Microbiome-Based Drugs and Diagnostics Market Key Performance Indicators |
9 Africa Human Microbiome-Based Drugs and Diagnostics Market - Export/Import By Countries Assessment |
10 Africa Human Microbiome-Based Drugs and Diagnostics Market - Opportunity Assessment |
10.1 Africa Human Microbiome-Based Drugs and Diagnostics Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Africa Human Microbiome-Based Drugs and Diagnostics Market Opportunity Assessment, By Drug Category, 2021 & 2031F |
10.3 Africa Human Microbiome-Based Drugs and Diagnostics Market Opportunity Assessment, By Diagnostic Category, 2021 & 2031F |
10.4 Africa Human Microbiome-Based Drugs and Diagnostics Market Opportunity Assessment, By Target Organism, 2021 & 2031F |
10.5 Africa Human Microbiome-Based Drugs and Diagnostics Market Opportunity Assessment, By Application Area, 2021 & 2031F |
10.6 Africa Human Microbiome-Based Drugs and Diagnostics Market Opportunity Assessment, By End Use, 2021 & 2031F |
11 Africa Human Microbiome-Based Drugs and Diagnostics Market - Competitive Landscape |
11.1 Africa Human Microbiome-Based Drugs and Diagnostics Market Revenue Share, By Companies, 2022 |
11.2 Africa Human Microbiome-Based Drugs and Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here